Serial Number
79301041
Owner
Bicycletx LimitedAttorney
Christina M. LicursiFiling Date
Oct 27, 2020
BICYCLE TUMOR-TARGETED IMMUNE CELL AGONIST Trademark
Serial Number: 79301041 • Registration: 6624273
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Christina M. Licursi Wolf, Greenfield & Sacks, P.C.
600 Atlantic Avenue
Boston, MA 02210
United States
Trademark Details
Filing Date
October 27, 2020
Registration Date
January 25, 2022
Published for Opposition
November 9, 2021
Goods & Services
Pharmaceutical products, namely, pharmaceutical preparations for use in oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders; pharmaceutical preparations for use as diagnostics, namely, diagnostic preparations for medical use and for use as clinical imaging agents
Scientific and technological services and research and design relating thereto, namely, scientific research, new product design services, and new study design services in the fields of the development of future human and veterinary medical treatments in the field of oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders, diagnostic preparations and clinical imaging agents; industrial analysis and research services in the fields of oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders, diagnostic preparations and clinical imaging agents; information, consultancy and advisory services relating to the aforesaid